You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

CIPROFLOXACIN EXTENDED RELEASE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ciprofloxacin Extended Release patents expire, and what generic alternatives are available?

Ciprofloxacin Extended Release is a drug marketed by Ani Pharms, Dr Reddys Labs Ltd, Endo Operations, Fosun Pharma, and Rising. and is included in five NDAs.

The generic ingredient in CIPROFLOXACIN EXTENDED RELEASE is ciprofloxacin; ciprofloxacin hydrochloride. There are thirty-four drug master file entries for this compound. Additional details are available on the ciprofloxacin; ciprofloxacin hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CIPROFLOXACIN EXTENDED RELEASE?
  • What are the global sales for CIPROFLOXACIN EXTENDED RELEASE?
  • What is Average Wholesale Price for CIPROFLOXACIN EXTENDED RELEASE?
Summary for CIPROFLOXACIN EXTENDED RELEASE
Drug patent expirations by year for CIPROFLOXACIN EXTENDED RELEASE
Recent Clinical Trials for CIPROFLOXACIN EXTENDED RELEASE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
British University In EgyptEarly Phase 1
Future University in EgyptPhase 1
Cairo UniversityN/A

See all CIPROFLOXACIN EXTENDED RELEASE clinical trials

US Patents and Regulatory Information for CIPROFLOXACIN EXTENDED RELEASE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms CIPROFLOXACIN EXTENDED RELEASE ciprofloxacin; ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 077809-002 Nov 30, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fosun Pharma CIPROFLOXACIN EXTENDED RELEASE ciprofloxacin; ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 078712-001 Dec 11, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dr Reddys Labs Ltd CIPROFLOXACIN EXTENDED RELEASE ciprofloxacin; ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 077701-001 Mar 26, 2007 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising CIPROFLOXACIN EXTENDED RELEASE ciprofloxacin; ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 078183-001 Mar 22, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ani Pharms CIPROFLOXACIN EXTENDED RELEASE ciprofloxacin; ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 077809-001 Nov 30, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dr Reddys Labs Ltd CIPROFLOXACIN EXTENDED RELEASE ciprofloxacin; ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 077701-002 Oct 31, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.